Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity (original) (raw)
Antioxidant Mechanism and Protection of Nigral Neurons Against MPP+ Toxicity by Deprenyl (Selegiline)
Ruey-meei Wu
Annals of the New York Academy of Sciences, 2006
View PDFchevron_right
Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
Russell Swerdlow
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
View PDFchevron_right
Neuronal antioxidant system and MPTP-induced oxidative stress in the striatum and brain stem of the rat
Giovanni Esposito
Pharmacology Biochemistry and Behavior, 1995
View PDFchevron_right
Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave …
Rebecca Angela
Journal of …
View PDFchevron_right
The Parkinsonian Neurotoxin 1-Methyl-4-Phenylpyridinium (MPP + ) Mediates Release of l -3,4-Dihydroxyphenylalanine ( l -DOPA) and Inhibition of l -DOPA Decarboxylase in the Rat Striatum: A Microdialysis Study
Glenn Dryhurst
Chemical Research in Toxicology, 2003
View PDFchevron_right
Toxic effects of MPP+ and MPTP in PC12 cells independent of reactive oxygen species formation
Michel Baudry
Brain Research, 2001
View PDFchevron_right
MPP+ toxicity in rat striatal slices: Relationship between non-selective effects and free radical production
Santiago Ambrosio
Neurochemical Research, 1996
View PDFchevron_right
Alterations in bioenergetic function induced by Parkinson’s disease mimetic compounds: lack of correlation with superoxide generation
Jacek Zielonka
Journal of Neurochemistry, 2012
View PDFchevron_right
Alterations in glutathione S-transferase pi expression following exposure to MPP+-induced oxidative stress in the blood of Parkinson’s disease patients
Richard Smeyne
Parkinsonism & Related Disorders, 2011
View PDFchevron_right
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine
Ritik Kumar
Life sciences, 1985
View PDFchevron_right
The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity
Julie Lotharius
The Journal of biological chemistry, 2000
View PDFchevron_right
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Julie Lotharius
Journal of Biological Chemistry, 2000
View PDFchevron_right
The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson's disease
Felipe Patricio Martinez
Neuroscience Research, 2021
View PDFchevron_right
Effects of MPTP, MPP+ and paraquat on mitochondrial potential and oxidative stress
Stephen C Bondy
Life Sciences, 1989
View PDFchevron_right
Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3-6-tetrahydropyridine (MPTP)-treated rat
L. Fresu
Neuroscience Letters, 1993
View PDFchevron_right
In vitro oxidation of MPTP by primate neural tissue: A potential model of MPTP neurotoxicity
Leonid Kelner
Neurochemistry International, 1985
View PDFchevron_right
Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease
Francesca Vaglini, Cristina Viaggi
Journal of Neurochemistry, 2004
View PDFchevron_right
Mechanism of the neurotoxicity of MPTP: An update
Rona Ramsay
Febs Letters, 1990
View PDFchevron_right
Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Rona Ramsay
Toxicology, 1988
View PDFchevron_right
Mechanism of the neurotoxicity of MPTP
Rona Ramsay
FEBS Letters, 1990
View PDFchevron_right
Oxidative Stress and Parkinson's Disease
Charulata Sankhla
Annals of the New York Academy of Sciences, 1996
View PDFchevron_right
Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP
Rona Ramsay
Life Sciences, 1986
View PDFchevron_right
Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains
N. Riachi
Brain Research, 1991
View PDFchevron_right
MPP+-Induced Mitochondrial Dysfunction Is Potentiated by Dopamine
Santiago Ambrosio
Biochemical and Biophysical Research Communications, 2000
View PDFchevron_right
Oxidative Stress and Parkinson’s Disease: Effects on Environmental Toxicology
Fermín Pacheco-Moisés
Free Radicals and Diseases, 2016
View PDFchevron_right
Free Radicals, Oxidative Stress and Oxidative Damage in Parkinson's Disease
Jorge A Serra
View PDFchevron_right
Antioxidant therapy in Parkinson's disease
Jay Thakar
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987
View PDFchevron_right
Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+
Rona Ramsay
Biochemical and Biophysical Research Communications, 1986
View PDFchevron_right
Rapid reduction of ATP synthesis and lack of free radical formation by MPP+ in rat brain synaptosomes and mitochondria
Michel Baudry
Brain Research, 2003
View PDFchevron_right
Antioxidant responses and lipid peroxidation following intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats: increased susceptibility of olfactory bulb
Pablo Pandolfo
Life Sciences, 2007
View PDFchevron_right
Coenzyme Q, peroxidation and cytochrome oxidase features after Parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria fromMacaca Fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine
Gian Paolo Littarru
Neurochemical Research, 1996
View PDFchevron_right
Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism
Rona Ramsay
Biochemical and Biophysical Research Communications, 1986
View PDFchevron_right
The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies
Joshua A Goldberg
Antioxidants & Redox Signaling, 2011
View PDFchevron_right
Impaired Mitochondrial functions and Energy Metabolism in MPTP-induced Model of Parkinson's Disease in Mice: Comparison of Strains and Dose Regimens
Anjana Pathania
2021
View PDFchevron_right
MPP+-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity
Ricardo Hernández
Neurotoxicity Research, 2003
View PDFchevron_right